Search Results - A. A. Spasov

Transition to the Non-Clinical Drug Development Principles and Rules of the Eurasian Economic Union: Changes, Challenges, and Prospects by A. A. Spasov

Connect to this object online.

Models of neuroinflammation for the assessment of kappa-opioid receptor ligands by K. Yu. Kalitin, A. A. Spasov, O. Yu. Mukha

Connect to this object online.

Electrophysiological effects of kappa-opioid analgesic, RU-1205, using machine learning methods by K. Yu. Kalitin, O. Yu. Mukha, A. A. Spasov

Connect to this object online.

HEMORHEOLOGICAL PROPERTIES OF THE 5-HT2A-ANTAGONIST OF THE 2-METHOXYPHENYL-IMIDAZOBENZIMIDAZOLE DERIVATIVE OF THE RU-31 COMPOUND AND CYPROHEPTADINE, IN COMPARISON WITH PENTHOXYPHYL... by D. S. Yakovlev, L. V. Naumenko, K. T. Sultanova, A. A. Spasov

Connect to this object online.

PHARMACOKINETIC PROPERTIES OF A NEW KAPPA-OPIOID ANALGESIC RU-1205 COMPOUND AT A SINGLE PERORAL ADMINISTRATION by A. A. Spasov, L. A. Smirnova, O. Yu. Grechko, N. V. Eliseeva, Yu. V. Lifanova, A. I. Rashchenko, O. N. Zhukovskaya, A. S. Morkovnik, V. A. Anisimova

Connect to this object online.

DF-5 COMPOUND DELAYS DEVELOPMENT OF DIABETIC NEPHROPATHY IN RATS by A. A. Spasov, O. N. Zhukovskaya, A. I. Rashchenko, A. A. Brigadirova, R. A. Litvinov, N. A. Gurova, A. V. Smirnov, N. G. Pan'shin, H. S.A. Abbas, A. S. Morkovnik

Connect to this object online.